Vynleads, Inc., a health and wellness technology company dedicated to helping members thrive naturally and stay out of the emergency room, is pleased to announce that the Company has graduated from the OTC Pink Open Market to the OTCQB Venture Market (“OTCQB”). Effective today, Vynleads now trades on the OTCQB under its ticker symbol “VYND.” Investors can find current financial disclosure and Real-Time Level 2 quotes for the company on www.otcmarkets.com.
“Graduating to the OTCQB Market is a significant milestone for Vynleads,” said Alex Mannine, Chief Executive Officer and co-founder of Vynleads. “We believe trading on the OTCQB will help increase liquidity and strengthen our shareholder base as we continue to establish our company as a leader in helping members to naturally manage, control and prevent type-2 diabetes.”
The OTCQB is the premier marketplace for entrepreneurial and development stage U.S. companies that are committed to providing a high-quality trading and information experience for investors. To be eligible, companies must be current in their financial reporting, pass a minimum bid price test, and undergo an annual company verification and management certification process. The OTCQB quality standards provide a strong baseline of transparency, as well as the technology and regulation to improve the information and trading experience for investors.
About Vynleads Inc.
Vynleads, Inc. is a health and wellness technology company dedicated to helping members thrive naturally and stay out of the emergency room. The Company is at the frontier of helping families manage, control and prevent type-2 diabetes and pre-diabetes naturally.
Vynleads’ flagship brand, “Done with Diabetes” (DWD), was introduced in 2016. Since its inception, DWD has acquired more than 28,000 paying members and generated more than USD$8M in gross revenues since its launch in March 2016. Vynleads plans to expand its Lifestyle Blueprint model, which powers DWD, across a range of verticals, with a focus on health and wellness support, and chronic illness management. Vynleads, Inc. is a fully reporting and audited company, with filings available on the SEC website.
Additional information about Vynleads is available at www.vynleads.com. Details about the DWD Protocol are available online at www.dwdprotocol.com and www.wearedwd.com.
Further information:
Alex Mannine
CEO and co-founder
Vynleads, Inc.
+1 (416) 489-0092
investors@vynleads.com
Media requests:
Adam Bello
Media & Analyst Relations Manager
Primoris Group Inc.
+1 (416) 489-0092 x 226
media@primorisgroup.com